NFKB1 and inflammatory bowel disease: Curcumin demonstrates substantial anti-inflammatory effects by interacting with toll-like receptors and regulating mediators, such as MAPK and NF-κB, making it a promising therapeutic agent for inflammatory bowel disease (IBD) [36,37].